United States · FDA National Drug Code directory
bumetanide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-525_58b3bb3b-6096-42fd-aebc-c856c3050071
- Product NDC
- 68382-525
- Form
- TABLET
- Composition / generic term
- bumetanide
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180501
- Source listing expiry
- 20261231
Source-listed ingredients
- BUMETANIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68382-525-01) · 68382-525-01
- 500 TABLET in 1 BOTTLE (68382-525-05) · 68382-525-05
- 30 TABLET in 1 BOTTLE (68382-525-06) · 68382-525-06
- 1000 TABLET in 1 BOTTLE (68382-525-10) · 68382-525-10
- 90 TABLET in 1 BOTTLE (68382-525-16) · 68382-525-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →